Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001

NCT07264569 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

42

Enrollment

OTHER_GOV

Sponsor class

Conditions

Meningeal Metastasis

Interventions

BIOLOGICAL: BioTTT001 injection

Sponsor

Henan Cancer Hospital